Allworth Financial LP Royalty Pharma PLC Transaction History
Allworth Financial LP
- $20.2 Billion
- Q2 2025
A detailed history of Allworth Financial LP transactions in Royalty Pharma PLC stock. As of the latest transaction made, Allworth Financial LP holds 2,862 shares of RPRX stock, worth $104,005. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,862
Previous 1,539
85.96%
Holding current value
$104,005
Previous $47,000
119.15%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding RPRX
# of Institutions
497Shares Held
307MCall Options Held
1.99MPut Options Held
384K-
Morgan Stanley New York, NY46.6MShares$1.69 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.4MShares$1.32 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$836 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA21.9MShares$795 Million0.14% of portfolio
-
Baillie Gifford & CO18MShares$655 Million0.51% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $15.9B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...